TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com
TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com
CHROMIUM 1882. HEALTH EFFECTSimproved industrial hygiene. Higher incidences of complaints of headache, tiredness, and lightheadedness were reported in housewives who lived in an area contaminated with chromium slag in Japanthan in housewives who lived in an uncontaminated area (Greater Tokyo Bureau of Hygiene 1989). Brainenlargement and cerebral edema were observed upon autopsy of a boy who died after ingesting potassiumdichromate (Kaufman et al. 1970). However, more chronic lower exposures to chromium(III) did notresult in any somatopsychic changes in patients on total parenteral nutrition (TPN) solutions (Lovrincevicet al. 1996). In this study, the TPN patients were examined for somatopsychic responses. A steadyincrease in serum chromium was found with length of time on TPN. In some patients, the serumchromium levels were near the upper normal value of 0.2 mg/L and others were up to 8- to 25-fold greaterthen normal values. No significant correlations were observed with respect to sleep disturbances, daytimemental changes, colorful dreams, frightening dreams, or nightmares.In animals, motor activity and ponderal balance decreased in rats dosed orally with 98 mgchromium(VI)/kg/day as sodium chromate for 28 days (Diaz-Mayans et al. 1986).It is unlikely that members of the general population would be exposed to concentrations ofchromium(VI) in air or drinking water high enough to cause neurological effects.Reproductive Effects. Female employees at dichromate manufacturing factories in Russia hadgreater incidences of complications during pregnancy and childbirth, toxicosis during pregnancy, andpostnatal hemorrhage than did controls (Shmitova 1978, 1980). The nature of the complications andtoxicosis was not specified. The poor quality and reporting of these studies preclude their use for drawingconclusions regarding potential reproductive effects of chromium in humans. However, in a study ofspontaneous abortion among 2,520 women whose spouses worked in the chromium stainless steelwelding industry, the rate of spontaneous abortions was not different from populations not exposed tochromium (Hjollund et al. 1995). The authors felt that their study was robust enough that confounderssuch as cigarette smoking and alcohol consumption did not influence their findings.In animals, oral exposure to chromium(VI) appears to adversely affect the reproductive system in malesand females. Testicular effects and alterations in sexual behavior have been observed following oral orparenteral exposure. In male mice fed potassium dichromate for 7 weeks, reduced sperm counts anddegeneration of the outer layer of the seminiferous tubules were seen at 15.1 mg chromium(VI)/kg/day,and morphologically altered sperm were seen at 28 mg chromium(VI)/kg/day (Zahid et al. 1990).Similarly, decreases in testicular weight, in testicular testosterone, Leydig cells, pachytene spermatocytes,
CHROMIUM 1892. HEALTH EFFECTSand stage-7 spermatids were found in male rats administered sodium dichromate(VI) by gavage for90 days at 20 mg chromium(VI)/kg/day (Chowdhury and Mitra 1995). These effects were not replicatedin potassium dichromate feeding studies conducted by NTP in which rats were exposed to 8.4 mgchromium(VI)/kg/day (NTP 1996b) and mice were exposed to 32.2 mg chromium(VI)/kg/day (NTP1996a). Alterations in sexual behavior, aggressive behavior, and decreases in absolute testes, seminalvesicles, and preputial glands weights were observed in male rats exposed to 42 mg chromium(VI)/kg/dayas potassium dichromate in drinking water (Bataineh et al. 1997). An increase in testes weight wasobserved in mice exposed to 6 mg chromium(VI)/kg/day as potassium dichromate for 12 weeks; at 14 mgchromium(VI)/kg/day, decreases in seminal vesicle and preputial gland weights were also observed(Elbetieha and Al-Hamood 1997). Intraperitoneal injection studies provide supporting evidence that themale reproductive system is a target of chromium(VI) toxicity. Intraperitoneal injections of rabbits with0.7 mg chromium(VI)/kg as potassium dichromate for 6 weeks resulted in morphological changes in thetestes consisting of marked edema of interstitial tissues, congestion of blood vessels, and completeabsence of spermatocytes in the seminiferous tubules (Behari et al. 1978). In rats receivingintraperitoneal injections of 2 or 3 mg chromium(VI)/kg as potassium dichromate for 69 days, a numberof dose-related testicular effects were observed including decreased sperm counts and motility, testiculartubules with disturbed spermatogenesis, decreased late stage spermatids and germ cell numbers at stageVII, and altered testicular enzyme levels (Saxena et al. 1990b). The pathological alterations were notseen after 34 days of exposure. In another study by this group, intraperitoneal injections of 2 mgchromium(VI)/kg/day as potassium dichromate resulted in ultrastructural changes in the testes (leakage ofSertoli cell tight junctions in seminiferous tubules, cytoplasmic vacuolization and degeneration ofmitochondira in the seminferous epithelium, and disruption of mitochondrial sheaths of tail midpieces ofspermatids) (Murthy et al. 1991).In females, a reduction in the number of medium- and large-sized follicles was noted in rats exposed to$60 mg chromium(VI)/kg/day as potassium dichromate in drinking water for 20 days (Murthy et al.1996). At higher concentrations, histological alterations in the ovaries, a decrease in the number ofova/mouse, and an increase in estrus cycle duration were observed. Additionally, delayed vaginalopening and impaired fertility were observed in female mouse offspring exposed to 66 mgchromium(VI)/kg/day as potassium dichromate in drinking water on gestational day 12 through lactationday 20 (Al-Hamood et al. 1998).Mixed results have been found in studies designed to assess the impact of chromium(VI) exposure onfertility. Two multigeneration studies in which rats were exposed to 0.2 mg chromium(VI)/m 3 as sodium
- Page 158 and 159: CHROMIUM 1382. HEALTH EFFECTS(2-5 m
- Page 160 and 161: CHROMIUM 1402. HEALTH EFFECTSIn rat
- Page 162 and 163: CHROMIUM 1422. HEALTH EFFECTSunstab
- Page 164 and 165: CHROMIUM 1442. HEALTH EFFECTSIn add
- Page 166 and 167: CHROMIUM 1462. HEALTH EFFECTSsignif
- Page 168 and 169: CHROMIUM 1482. HEALTH EFFECTS2.3.4.
- Page 170 and 171: CHROMIUM 1502. HEALTH EFFECTSDaily
- Page 172 and 173: CHROMIUM 1522. HEALTH EFFECTS51 Chr
- Page 174 and 175: CHROMIUM 1542. HEALTH EFFECTS2.3.5
- Page 176 and 177: CHROMIUM 1562. HEALTH EFFECTSFigure
- Page 178 and 179: CHROMIUM 1582. HEALTH EFFECTSTable
- Page 180 and 181: CHROMIUM 1602. HEALTH EFFECTSFigure
- Page 182 and 183: CHROMIUM 1622. HEALTH EFFECTSInterr
- Page 184 and 185: CHROMIUM 1642. HEALTH EFFECTSthe bl
- Page 186 and 187: CHROMIUM 1662. HEALTH EFFECTSpreval
- Page 188 and 189: CHROMIUM 1682. HEALTH EFFECTS2.5 RE
- Page 190 and 191: CHROMIUM 1702. HEALTH EFFECTSSevera
- Page 192 and 193: CHROMIUM 1722. HEALTH EFFECTSanimal
- Page 194 and 195: CHROMIUM 1742. HEALTH EFFECTSOral M
- Page 196 and 197: CHROMIUM 1762. HEALTH EFFECTSfibros
- Page 198 and 199: CHROMIUM 1782. HEALTH EFFECTSNausea
- Page 200 and 201: CHROMIUM 1802. HEALTH EFFECTSthe pr
- Page 202 and 203: CHROMIUM 1822. HEALTH EFFECTSSevere
- Page 204 and 205: CHROMIUM 1842. HEALTH EFFECTSdevelo
- Page 206 and 207: CHROMIUM 1862. HEALTH EFFECTSthe ce
- Page 210 and 211: CHROMIUM 1902. HEALTH EFFECTSchroma
- Page 212 and 213: CHROMIUM 1922. HEALTH EFFECTSIn ano
- Page 214 and 215: Table 2-5. Genotoxicity of Chromium
- Page 216 and 217: Table 2-5. Genotoxicity of Chromium
- Page 218 and 219: Species (test system)Prokaryotic or
- Page 220 and 221: Species (test system)S. typhimurium
- Page 222 and 223: Species (test system)Mouse A18BcR c
- Page 224 and 225: Species (test system)Prokaryotic or
- Page 226 and 227: Species (test system)Syrian hamster
- Page 228 and 229: CHROMIUM 2082. HEALTH EFFECTSet al.
- Page 230 and 231: CHROMIUM 2102. HEALTH EFFECTScancer
- Page 232 and 233: CHROMIUM 2122. HEALTH EFFECTS2.6 EN
- Page 234 and 235: CHROMIUM 2142. HEALTH EFFECTSChromi
- Page 236 and 237: CHROMIUM 2162. HEALTH EFFECTSchromi
- Page 238 and 239: CHROMIUM 2182. HEALTH EFFECTSBiolog
- Page 240 and 241: CHROMIUM 2202. HEALTH EFFECTSFigure
- Page 242 and 243: CHROMIUM 2222. HEALTH EFFECTSemploy
- Page 244 and 245: CHROMIUM 2242. HEALTH EFFECTSunexpe
- Page 246 and 247: CHROMIUM 2262. HEALTH EFFECTSMutti
- Page 248 and 249: CHROMIUM 2282. HEALTH EFFECTS1986a,
- Page 250 and 251: CHROMIUM 2302. HEALTH EFFECTSconcen
- Page 252 and 253: CHROMIUM 2322. HEALTH EFFECTSmentio
- Page 254 and 255: CHROMIUM 2342. HEALTH EFFECTS2.11.2
- Page 256 and 257: CHROMIUM 2362. HEALTH EFFECTSglutat
<strong>CHROMIUM</strong> 1892. HEALTH EFFECTSand stage-7 spermatids were found in male rats administered sodium dichromate(VI) by gavage for90 days at 20 mg chromium(VI)/kg/day (Chowdhury and Mitra 1995). These effects were not replicatedin potassium dichromate feeding studies conducted by NTP in which rats were exposed to 8.4 mgchromium(VI)/kg/day (NTP 1996b) and mice were exposed to 32.2 mg chromium(VI)/kg/day (NTP1996a). Alterations in sexual behavior, aggressive behavior, and decreases in absolute testes, seminalvesicles, and preputial glands weights were observed in male rats exposed to 42 mg chromium(VI)/kg/dayas potassium dichromate in drinking water (Bataineh et al. 1997). An increase in testes weight wasobserved in mice exposed to 6 mg chromium(VI)/kg/day as potassium dichromate for 12 weeks; at 14 mgchromium(VI)/kg/day, decreases in seminal vesicle and preputial gland weights were also observed(Elbetieha and Al-Hamood 1997). Intraperitoneal injection studies provide supporting evidence that themale reproductive system is a target of chromium(VI) toxicity. Intraperitoneal injections of rabbits with0.7 mg chromium(VI)/kg as potassium dichromate for 6 weeks resulted in morphological changes in thetestes consisting of marked edema of interstitial tissues, congestion of blood vessels, and <strong>com</strong>pleteabsence of spermatocytes in the seminiferous tubules (Behari et al. 1978). In rats receivingintraperitoneal injections of 2 or 3 mg chromium(VI)/kg as potassium dichromate for 69 days, a numberof dose-related testicular effects were observed including decreased sperm counts and motility, testiculartubules with disturbed spermatogenesis, decreased late stage spermatids and germ cell numbers at stageVII, and altered testicular enzyme levels (Saxena et al. 1990b). The pathological alterations were notseen after 34 days of exposure. In another study by this group, intraperitoneal injections of 2 mgchromium(VI)/kg/day as potassium dichromate resulted in ultrastructural changes in the testes (leakage ofSertoli cell tight junctions in seminiferous tubules, cytoplasmic vacuolization and degeneration ofmitochondira in the seminferous epithelium, and disruption of mitochondrial sheaths of tail midpieces ofspermatids) (Murthy et al. 1991).In females, a reduction in the number of medium- and large-sized follicles was noted in rats exposed to$60 mg chromium(VI)/kg/day as potassium dichromate in drinking water for 20 days (Murthy et al.1996). At higher concentrations, histological alterations in the ovaries, a decrease in the number ofova/mouse, and an increase in estrus cycle duration were observed. Additionally, delayed vaginalopening and impaired fertility were observed in female mouse offspring exposed to 66 mgchromium(VI)/kg/day as potassium dichromate in drinking water on gestational day 12 through lactationday 20 (Al-Hamood et al. 1998).Mixed results have been found in studies designed to assess the impact of chromium(VI) exposure onfertility. Two multigeneration studies in which rats were exposed to 0.2 mg chromium(VI)/m 3 as sodium